Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,576 | 8,740 | 12,620 | 13,159 | 63,458 |
| Marketable Securities | 52,174 | 43,224 | 14,529 | 29,144 | 5,993 |
| Receivables | 37 | 75 | 26 | 588 | 507 |
| TOTAL | $58,214 | $54,407 | $27,956 | $43,664 | $71,312 |
| Non-Current Assets | |||||
| PPE Net | 220 | 151 | 236 | 353 | 451 |
| Investments And Advances | 10,991 | 12,540 | 16,123 | 21,877 | 34,266 |
| Other Non-Current Assets | 1,694 | 1,809 | 1,238 | 2,346 | 3,426 |
| TOTAL | $12,905 | $14,500 | $17,597 | $24,576 | $38,143 |
| Total Assets | $71,119 | $68,907 | $45,553 | $68,240 | $109,455 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,491 | 2,582 | 1,525 | 1,976 | 1,565 |
| Accrued Expenses | 6,486 | 3,725 | 3,970 | 7,548 | 7,081 |
| Other current liabilities | N/A | 28,910 | N/A | N/A | N/A |
| TOTAL | $9,380 | $35,402 | $6,869 | $10,752 | $9,692 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 534 | 937 | 0 | 1,373 | 2,601 |
| TOTAL | $534 | $937 | $N/A | $1,373 | $2,601 |
| Total Liabilities | $9,914 | $36,339 | $6,869 | $12,125 | $12,293 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,992 | 68,136 | 49,039 | 46,569 | 46,554 |
| Common Shares | 7 | 7 | 5 | 5 | 5 |
| Retained earnings | -412,293 | -397,010 | -334,717 | -307,688 | -266,381 |
| Other shareholders' equity | -896 | -1,288 | -967 | -563 | 1,869 |
| TOTAL | $61,205 | $32,568 | $38,684 | $56,115 | $97,162 |
| Total Liabilities And Equity | $71,119 | $68,907 | $45,553 | $68,240 | $109,455 |